From: Inconsistency analysis between metagenomic next-generation sequencing results of cerebrospinal fluid and clinical diagnosis with suspected central nervous system infection
Sensitivity
Specificity
mNGS/conventional methods
90.91% (10/11)
63.33% (19/30)
mNGS/clinical diagnosis
54.84% (17/31)
60.00% (6/10)
Conventional methods/clinical diagnosis
32.26% (10/31)
90.00% (9/10)